期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
The HMGB1 signaling pathway activates the inflammatory response in Schwann cells 被引量:5
1
作者 Li-li Man Fan Liu +5 位作者 Ying-jie Wang Hong-hua Song Hong-bo Xu zi-wen zhu Qing Zhang Yong-jun Wang 《Neural Regeneration Research》 SCIE CAS CSCD 2015年第10期1706-1712,共7页
Schwann cells are not only myelinating cells, but also function as immune cells and express numerous innate pattern recognition receptors, including the Toll-like receptors. Injury to peripheral nerves activates an in... Schwann cells are not only myelinating cells, but also function as immune cells and express numerous innate pattern recognition receptors, including the Toll-like receptors. Injury to peripheral nerves activates an inflammatory response in Schwann cells. However, it is unclear whether specific endogenous damage-associated molecular pattern molecules are involved in the inflammatory response following nerve injury. In the present study, we demonstrate that a key damage-associated molecular pattern molecule, high mobility group box 1(HMGB1), is upregulated following rat sciatic nerve axotomy, and we show colocalization of the protein with Schwann cells. HMGB1 alone could not enhance expression of Toll-like receptors or the receptor for advanced glycation end products(RAGE), but was able to facilitate migration of Schwann cells. When Schwann cells were treated with HMGB1 together with lipopolysaccharide, the expression levels of Toll-like receptors and RAGE, as well as inflammatory cytokines were upregulated. Our novel findings demonstrate that the HMGB1 pathway activates the inflammatory response in Schwann cells following peripheral nerve injury. 展开更多
关键词 nerve regeneration peripheral nerve injury sciatic nerve transection Schwann cells HMGB1 migration inflammatory response TLRs peripheral nerves DAMPs cytokines neural regeneration
下载PDF
Different Strategies for Preparation of Non-tagged rV270 Protein and Its Efficacy against Yersinia Pestis Challenge 被引量:1
2
作者 WANG WANG ZHI-ZHEN QI +12 位作者 QING-WEN ZHANG BEN-CHUAN WU zi-wen zhu YONG-HAI YANG BAI-ZHONG CUI RUI-XIA DAI YE-FENG QIU ZU-YUN WANG ZHAO-BIAO GUO TAO-XING SHI HU WANG RUI-FU YANG XIAO-YI WANG 《Biomedical and Environmental Sciences》 SCIE CAS CSCD 2010年第5期333-340,共8页
Objective LcrV is an important component for the development of a subunit vaccine against plague.To reduce immunosuppressive activity of LcrV,a recombinant LcrV variant lacking amino acids 271 to 326 (rV270) was pre... Objective LcrV is an important component for the development of a subunit vaccine against plague.To reduce immunosuppressive activity of LcrV,a recombinant LcrV variant lacking amino acids 271 to 326 (rV270) was prepared by different methods in this study.Methods A new strategy that produced non-tagged or authentic rV270 protein was designed by insertion of rV270-thrombin-hexahistidine fusion gene into the vector pET24a,or by insertion of hexahistidine-enterokinase-rV270 or hexahistitine-factor Xa-rV270 fusion gene into the vector pET32a.After Co2+ affinity chromatography,a purification strategy was developed by cleavage of His tag on column,following Sephacryl S-200HR column filtration chromatography.Results Removal of His tag by thrombin,enterokinase and factor Xa displayed a yield of 99.5%,32.4% and 15.3%,respectively.Following Sephacryl S-200HR column filtration chromatography,above 97% purity of rV270 protein was obtained.Purified rV270 that was adsorbed to 25% (v/v) Al(OH)3 adjuvant in phosphate-buffered saline (PBS) induced very high titers of antibody to rV270 in BALB/c mice and protected them (100% survival) against subcutaneous challenge with 106 CFU of Y.pestis virulent strain 141.Conclusion The completely authentic rV270 protein can be prepared by using enterokinase or factor Xa,but they exhibited extremely low cleavage activity to the corresponding recognition site.Thrombin cleavage is an efficient strategy to prepare non-tagged rV270 protein and can be easily operated in a large scale due to its relatively low cost and high cleavage efficacy.The recombinant rV270 can be used as a key component to develop a subunit vaccine of plague. 展开更多
关键词 Yersinia pestis rV270 antigen PURIFICATION Protection PLAGUE
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部